Nanding, Norseda P.
HRN: 26-85-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2025
AMPICILLIN 1GM (VIAL)
04/10/2025
04/11/2025
IVT
2g
Q6
PROM X 1 Hour
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes